Webinar: Updated DHIS2 HIV toolkit

Join the DHIS2 Health Toolkit team from the HISP Centre and experts from the WHO HIV Programme for an informative online session on the new DHIS2 toolkit for HIV prevention and case surveillance. This event will include a presentation on the integration of WHO SMART guidelines into the DHIS2 HIV toolkit, plus real-world examples of country implementations.

This webinar will take place on Thursday 14 March from 14:00-15:30 CET. Register to join us on Zoom here: Meeting Registration - Zoom


for client characteristics, can the system track pregnancy and breastfeeding periods?

Dear @justkat,
first of all thank you very much for your partecipation on the webinar.
Related to your question it’s possible to track these characteristics and actaully, in the HIV Case Surveillance tracker we are already doing it visit by visit related to the pregnancy status but us well the breastfeeding on the vertical transmission section

how does the key population data stay separate from identifying characteristics but still track with the client over time?

Thank you, this is helpful. I am working on PrEP so looking at this through a PrEP lens.

I was interested in knowing whether it would be possible to assess outcomes related to triple elimination (HIV, HepB, and syphilis) through the tracker?

Key population data is collected as a program stage in order to further protect the sensitive nature of this data. Specifically, by including this data only in the program stage, it is not accessible for searching a TEI – where users may have broader access to search for clients.
Collecting data on key populations poses certain challenges, particularly when information is linked or shared across service providers and programmes. All individual-level health data, including those of key populations, must be classified as sensitive personal data, or personally identifiable information, that require a high standard of safety and security. All health information systems must have robust data security and confidentiality protocols in place to safeguard data, supported by laws and policies that protect health information. The processing of personal health data must address cybersecurity, trust building, accountability and governance, ethics, equity, capacity building and digital literacy.

Where safety and the potential to discourage access to services are a concern, the routine collection of key population information is not advised; and should be removed from the digitized DHIS2 Prevention Tracker Program. Similarly, before capturing personally identifiable data such as client name, birth date and other indirectly identifiable data, a risk assessment and security review of the electronic systems and SOPs for all users must be reviewed and gaps addressed.

You can refer for more information to the System design guide of both HIV Case Surveillance and Prevention program

1 Like

Concerning PrEP you’ll find more information on the HIV Prevention tracker.
I encourage you to have a look to the demo site and specifically to the HIV prevention tracker.
You can play around and add any patients that you want.
There is as well a specific dashboard for PrEP where you can find an example of visualisations that were elaborated in collaboration with WHO.
All the following three indicators from the latest WHO guidelines and their disaggregations can be calculated with the actual program
And they are included in the indicator group HIV Prevention - WHO standard list [K6esSqLr8Ta]

Don’t hesitate to contact us if further doubts/questions!

1 Like

Dear @sbrar,
informations related HepB and syphilis are collected in both programs (HIV Prevention and Case Surveillance) and the informations collected are the ones needed for the calculation of the indicators present on the WHO Consolidated guidelines on person-centred HIV strategic information: strengthening routine data for impact analysis framework.
The indicators with their relatives disaggregations related to HepB and syphilis served are the following:

The information collected are speficics for an HIV program (either prevention and/or Case Surveillance) therefore doesn’t take in account syphilis and HepB management of patients that are not part of these programs.
We can therefore says that the current DHIS2 HIV toolkit cover the information related the triple elimination for the patients enrolled in an HIV program but need to be completed with the syphilis and HepB information coming out of it.

The flat structure of both programs can be easilt adapted to accomodate the information needed for the triple information if needed.

Let me know if this answer your questions and don’t hesitate to contact us in case of doubts/questions!

1 Like

Dear all,

The recording of the webinar is available below and you have access to the presentation here


Good! Thank you for your information!

1 Like